Gem Pharmaceuticals is Drug Discovery in United States that focus on drug combinations business. Founded in 2001. They cover business area such as developer, anthracycline derivative, this powerful class, chemotherapeutic, their well-document anti-cancer efficacy, traditional broad-spectrum cytotoxic drug, modern and biochemically target anti-cancer agent, high cumulative dosing, previously problematic drug combination, doctor, therapeutic utility.
2001
( 23 years old in 2024 )
Drug Combinations
-
941 Lake Forest Circle
Birmingham, AL 35244
United States
Private
developeranthracycline derivativethis powerful classchemotherapeutictheir well-document anti-cancer efficacytraditional broad-spectrum cytotoxic drugmodern and biochemically target anti-cancer agenthigh cumulative dosingpreviously problematic drug combinationdoctortherapeutic utility
* We use standard office opening hours in near Gem Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Gem Pharmaceuticals is Drug Discovery business from United States that founded in 2001 (23 years old in 2024), Gem Pharmaceuticals business is focusing on Drug Combinations.
Gem Pharmaceuticals headquarter office and corporate office address is located in 941 Lake Forest Circle Birmingham, AL 35244 United States.
Gem Pharmaceuticals was founded in United States.
In 2024, Gem Pharmaceuticals is currently focus on drug combinations sector.
Above is snippet of Google Trends for "drug combinations" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Gem Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
